Section Review Biologicals & Immunologicals: Deregulation of cytokine production in AIDS: implication for therapy

References

• AUKRUST P, LIABAKK NB, MULLER F, LIEN E, ESPEVIK, T, FROLAND SF: Serum levels of tumour necrosis factor-a and soluble INF receptors in human immunodefi-ciency virus type 1 infection. Correlations to clinical, Immunologic, and virologic parameters. J. Inf. Dis. (1994) 169:420–424.
   Google Scholar
• BMX DL, REDFIELD RR, TENCER K, FOWLER A, BURKE DS, TOSATO G: Induction of interleukin-6 during Human Immunodeficiency Virus infection. Blood(1990)76:2303–2310.
   PubMed Web of Science ®Google Scholar
• BREEN EC, REZAL AR, NAKAJIMA K, BEALL GN, MIT-SUYASU RT, HIRANO T, KISHIMOTO T, MARTINEZ-MAZA O: Infection with mV is associated with elevated IL-6 levels and production. J. Immunol. (1990) 144:480–484.
   PubMed Web of Science ®Google Scholar
• WEISS L, HAEFFNER-CAVAILLON N, LAUDE M, GILQUIN J, KAZATCHKINE MD: IIIV infection is associated with the spontaneous production of interleukin-1 in vivo and with an abnormal release of IL-la in vitro. AIDS (1989) 3:695–699.
   PubMed Web of Science ®Google Scholar
• EMILIE D, PEUCHMAUR M, MAILLOT M-C, CREVON M-C, BROUSSE N, DELFRAISSY J-F, DORMONT J, GALANAUD P:Production of interleukins in human immunodefi-ciency virus-l-replicating lymph nodes. J. Clin. Invest. (1990) 86:148–159.
   PubMed Web of Science ®Google Scholar
• GRAZIOSI C, PANTALEO G, GANTT KR, FORTIN JP, DE- MAREST JF, COHEN OJ, SEKALI RP, FAUCI AS: Lack ofevidence for the dichotomy of Thl and Th2 predomi-nance in HIV-infected patients. Science (1994) 265:248–252.
   PubMed Web of Science ®Google Scholar
• WESTENDORP MO, SHATROV VA, SCHULZE-OSTHOFF K,FRANK R, KRAFT M, LOS M, 'CRAMMER PH, DROGE W, LEHMAN V: HIV-1 Tat potentiates TNF-induced NF-kft activation and cytotoxicky by altering the cellular re-dox state. EMBOJ. (1995) 14:546–554.
   PubMed Web of Science ®Google Scholar
• BORGHI P, FANTUZZI L, VARANO B, GESSANI S, PUDDU P, CONTI L, ROSAR1A M, CAPOBIANCHI MR, AMEGLIO F, BELARDELLI F: Induction of interleukin-10 by human ircununodeficiency virus type 1 and its gp120 protein In human monocytes/rnacrophages. J. Virol. (1995) 69:1284–1287.
   PubMedGoogle Scholar
• AKRIDGE RE, OYAFUSO LKM, REED SG: EL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. (1994) 153:5782–5789.
   PubMed Web of Science ®Google Scholar
• MASOOD R, LUNARDI-ISKANDER Y, MOUDGIL T, ZHANGY, LAW RE, HUANG CL, PURI RK, LEVINE AM, GILL PS: IL-10 inhibits HIV-1 replication and is induced by tat. Bio-chem. Biophys. Res. Commun. (1994) 202:374–383.
   PubMed Web of Science ®Google Scholar
• AMEGLIO F, CAPOBIANCHI MR, CASTILLETI C, CORDIALI-FEI P, FAIS S, TRENTO E, DIANZANI F: Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells. Correlation with the induction of other cytokines. Clin. Exp. Immunol. (1994) 95:455–458.
   PubMed Web of Science ®Google Scholar
• EMILIE D, FIOR R, LLORENTE L, MARFAING-KOKA A, PEUCHMAUR M, DEVERGNE O, JARROUSSE B, W1JDENES J, BOUE F, GALANAUD P: Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B-lymphomas. Immunol. Rev. (1994) 140:5–34.
   PubMed Web of Science ®Google Scholar
• EMILIE D, FIOR R, CREVON MC, MA1LLOT MC, BOUE F, GALANAUD P: Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease. Res. Immunol. (1995) 145:595–604.
   Google Scholar
• DENTS M, GHADIRIAN E: Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res. Human Retroviruses (1994) 10:1619–1627.
   PubMed Web of Science ®Google Scholar
• GALLO P, srvIERI S, RINALDI L, YAN XB, LOLLI F, DE ROSSI A, TAVOLATO B: Intrathecal synthesis of interleukin 10 In viral and inflammatory diseases of the central nerv-ous system. J. Neurol. Sci. (1994) 126:49–53.
   PubMed Web of Science ®Google Scholar
• RIMANIOL AC, BOUSSIN F, HERBELIN A, DEGROOTE D, DORMONT D, BACH JF, DESCAMPS-LATSCHA B, ZAVALA F: Induction of soluble tumor necrosis factor receptor (sREN-R75) release by HIV adsorption on cultured hu-man monocytes. Eur.J. Immunol. (1994) 24:2055–2060.
   PubMed Web of Science ®Google Scholar
• GODFRIED MH, VAN DER POLL T, WEVERLING GJ, MULDER JW, JANSEN J, VAN DEVENTER SJH, SAUERWEIN HP: Soluble receptors for tumor necrosis factor as predic-tors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis. (1994) 169:739–745.
   PubMed Web of Science ®Google Scholar
• CHEHIMI J, STARR SE, FRANK I, D'ANDREA A, MA X, MACGREGOR RR, SENNELIER J, TRINCH1ERI G: Impairedinterleukin 12 production in human immunodefi-ciency virus-infected patients. J. Exp. Med. (1994) 179 :1361–1366.
   PubMed Web of Science ®Google Scholar
• LANE HC, DEPPER JM, GREENE WC, WHALEN G, WALD- MANN TA, FAUCI AS: Qs aittative analysis of immune function in patients with the acquired immunodefi-ciency syndrome. Evidence for a selective defect in soluble antigen recognition. New Engl. J. Med. (1985) 313:79–84.
   Google Scholar
• CLERICI M, HAKIM FT, VENZON DJ, BLATT S, HENDRIXCW, WYNN TA, SHEARER GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, Human Ircununodeficiency Virus-seropositive individuals. J. Chn. Invest. (1993) 91:759–765.
   PubMed Web of Science ®Google Scholar
• MEYAARD L, SCHLTITEMAKER H, MIEDEMA F: T-cell dys- function in HIV infection: anergy due to defective anti-gen-presenting cell function? Immunol. Today (1993) 14:161–164.
   Google Scholar
• CEFAI D, DEBRE P, KACZOREK M, IDZIOREK T, AUTRAN B, BISMUTH G: 111V-1 giycoproteins gp120 and gp160 specifically inhibit the CD3/T-cell-antigen receptor phosphoinositide transduction pathway. J. Clin. Invest. (1990) 86:2117–2124.
   PubMed Web of Science ®Google Scholar
• HIVROZ C, MAZEROI IFS F, SOLA M, FAGARD R, GRATON S, MELOCHE S, SEKALY R, FISCHER A: BEIV gp120 and derived peptides activate protein tyrosine kinase p561cic in human CD4 T-lymphocytes. Eur. j Immunol. (1993) 23:600–607.
   PubMed Web of Science ®Google Scholar
• KOVACS JA, BASELER M, DEWAR RJ, VOGEL S, DAVEY RT, FALLOON J, POLIS MA, WALKER RE, STEVENS R, SALZMAN NP, METCALF JA, MASUR H, LANE HC: Increases in CD4 T-lymphocytes with intermittent courses of inter-leulcin-2 in patients with human incununodeficiency virus infection. New Engl. J. Med. (1999 332:567–575.
   Google Scholar
• TEPPLER H, KAPLAN G, SMITH K, CAMERON P, MONTANA A, MEYN P, COHN Z: Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodefidency virus type 1 infection. J. Infect. Dis. (1993) 167:291–298.
   PubMed Web of Science ®Google Scholar
• TEPPLER H, KAPLAN G, SMITH KA, MONTANA AL, MEYN P, COHN ZA: Prolonged immunostitnulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J. Exp. Med. (1993) 177:483–492.
   PubMed Web of Science ®Google Scholar
• CLERICI M, SHEARER GM: A Th1-Th2 switch is a critical step in the etiology of 111V infection. Immunol. Today (1993) 14:107–110.
   PubMedGoogle Scholar
• BOYLE MJ, BERGER MF, TSCHUCNIGG M, VALENTINE JE,KENNEDY BG, DIVJAK M, COOPER DA, TURNER JJ, PENNY R, SEWELL WA: Increased expression of interferon-gamma in hyperpiastic lymph nodes from 11W-infected patients. Clin. Exp. Immunol. (1993) 92:100–105.
   PubMed Web of Science ®Google Scholar
• LLORENTE L, RICHAUD-PATIN Y, FIOR R, ALCOCER-VARELA J, WIJDENES J, MOREL FOURRIER B, GALANAUD P, EMILIE D: In vivo production of interleukin-10 by non-T-cells in rheumatoid arthritis, SjOgren's syn-drome and systemic lupus erythematosus: a potential mechanism of B-lymphocyte hyperactivity and autolm-munity. Arthritis Rheum. (1994) 37:1647–1655.
   PubMed Web of Science ®Google Scholar
• ROMAGNANI S, DEL PRETE G, MANETTI R, RAVINA A, ANNUNZIATO F, DE CARLI M, MAZZETTI M, PICCINNI MP, D'ELIOS MM, PARRONCHI P, SAMPOGNARO S, MAGGI E: Role of Thl/Th2 cytokines in HIV infection. Immunol. Rev. (1994) 140:73–92.
   PubMed Web of Science ®Google Scholar
• CHEHIMI J, STARR SE, FRANK I, RENGARAJU M, JACKSON SJ, LLANES C, KOBAYASHI M, PERUSSIA B, YOUNG D,NICKBARG E, WOLFF SF, TRINCHIERI G: NK cell stimula-tory factor increases the cytotoxic activity of NI( cells from both healthy donors and 11W-Infected patients. J. Exp. Med. (1992) 175:789–796.
   PubMed Web of Science ®Google Scholar
• CLERICI M, LUCEY D, BERZOFSKY J, PINTO LA, WYNN TA, BLATT SP, DOLAN MJ, HENDRIX CW, WOLF SF, SHEARERGM: Restoration of 11W-specific cell-mediated immune responses by interleukin 12 in vitro. Science (1993) 262: 1721-1724.
   Google Scholar
• CLERICI M, WYNN TA, BERZOFSKY JA, BLATT SP, HENDRIX CW, SHER A, COFFMAN RE, SHEARER GM: Role of inter-leukln-10 in T helper cell dysfunction in asymptomatic Individuals infected with 11W. J. Clin. Invest. (1994) 93:768–777.
   PubMed Web of Science ®Google Scholar
• ZHANG M, GONG J, LYER DV, JONES BE, MODLIN EL, BARNES PF: T-cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infec-tion. J. Chn. Invest. (1994) 94:2435–2442.
   PubMed Web of Science ®Google Scholar
• BIATT SP, HENDRIX CW, BUTZIN CA, FREEMAN TM, WARD WW, HENSLEY RE, MELCHER GP, DONOVAN DJ, BOS WELL RN: Delayed-type hypersensitivity skin testing predicts progression to AIDS in 11W-Infected patients. Ann. In-tern. Med. (1993) 119:177–183.
   PubMed Web of Science ®Google Scholar
• LUCEY DR, MELCHER GP, HENDRIX CW, ZAJAC RA, GOETZ DW, BUTZIN CA, CLERICI M, WARNER RD, ABBADESSA S, HALL K: The US Air Force HIV study 1985-1990: immu-nological analyses, seroconversion and the potential utility of a T-helper functional assay to predict change In CD4 T-cell counts during early stage HIV infection J. Inf Dis. (1991) 164:631–637.
   PubMedGoogle Scholar
• SCHUITEMAKERN H, MEYAARD L, KOOSTRA NA, DUBBESR, OTTO SA, TERSME1 it. M, HEENEY JL, MIEDEMA F: Lack of T-cell dysfunction and programmed cell death in 11W type- 1-infected chimpanzees correlates with absence of monocytotropic variants. J. inf. Dig. (1993) 168:1140–1147.
   Google Scholar
• MOSIER DE, GULIZIA RJ, MACISAAC PD, TORBETT BE. LEVY JA: Rapid loss of ON' T-cells in human-PBL-SCLD mice by noncytopathic ILW isolates. Science (19931 260:689–692.
   Google Scholar
• HO DD, NEUMAN AU, PERELSON AS, CHEN W, LEONARD JM, MARKOWITZ M: Rapid turnover of plasma virions and CD4 lymphocytes in IfIV-1 infection. Nature (1995) 373:123–126.
   PubMed Web of Science ®Google Scholar
• CLERICI M, SARIN A, COFFMAN RL, WYNN TA, BLATT SP,HENDRIX CW, WOLF SF, SHEARER GM, HENKART PA: Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl, Acad. Sci. USA (1994) 91:11811–11815.
   PubMed Web of Science ®Google Scholar
• ESTAQUIER J, IDZIOREK T, ZOU W, EMILIE D, FARBER CM, BOUREZ JM, AMEISEN JC: Thl/Th2 cytokines and T-cell death: preventive effect of 11–12 on activation induced and CD95 (FAS/APO-1) mediated apoptosis of CD4+ T-cells from HIV-infected persons. Submitted for publica-tion
   Google Scholar
• MAGGI E, GIUDIZI MG, BIAGIOTTI R, ANNUNZIATO F, MANETTI R, PICCINNI MP, PARRONCHI P, SAMPOGNARO S, GIANNARINI L, ZUCCATI G, ROMAGNANI S: Th2-like CDs* T-cells showing B-cell helper function and re-duced cytolytic activity in HIV type 1 infection. J. EXp. Med. (1994) 180:489–495.
   PubMed Web of Science ®Google Scholar
• MARFAING-KOKA A, AUBIN yr, GRANGEOT-KEROS L, PORTIER A, BENATTAR C, MERRIEN D, AGUT H, AUCOU-TURIER P, AUTRAN B, WIJDENES J, GALANAUD P, EMILIE D: In vivo role of IL-6 on the viral load and on immu-nological abnormalities of HIV-infected patients. J. AIDS Hum. Retrovtruses (In press).
   Google Scholar
• AGOSTI JM, COOMBS RW, COLLIER AC, PARADISE MA,BENEDETTI JK, JAFFE HS, COREY L: A randomized dou-ble-blind, Phase I/II trial of tumor necrosis factor and Interferon-gamma for treatment of AIDS-related com-plex (Protocol 025 from the AIDS Clinical Trials Group). AIDS Res. Hum. Retroviruses (1992) 8:581–587.
   PubMed Web of Science ®Google Scholar
• LEVINE JD, ALLAN JD, TESSITORE JI-1, FALCONE N. GALASSO F, ISRAEL RJ, GROOPMAN JE: Recombinant human granulocyte-macrophage colony stimulating factor ameliorates Zidovudine induced neutropenia in patients with acquired immunodefkiency syndrome (AIDS)/AIDS related complex. Blood (1991) 78:3148–3154.
   Google Scholar
• DEZUBE BJ, LEDERMAN MM, SPRITZLER JG, CHAPMAN B, KORVICK JA, FLEXNER C, DANDO S, MATTIACI M, AHLERS CM, ZHANG L, NOVICK WJ, KASDAN P, FAHEY JL, PARDEE AB, CRUMPACKER CS: High dose pentoxifylline in pa-tients with AIDS: inhibition of tumor necrosis factor production. J. Inf. Dis. (1995) 171:1628–1632.
   PubMed Web of Science ®Google Scholar
• NAVARRO J, PIZARRO A, FERNANDEZ-CRUZ E, FRESNO M, MUNOZ-FERNANDEZ: Pentoxifylline preferentially in-hibits interleukin-10 production by HIV-I-infected hu-man T-celLs. AIDS (1994) 8:1192–1194.
   PubMed Web of Science ®Google Scholar
• MAKONKAWKAYOON S, LIMSON PROBRE RN, MOREIRAAL, SCHAUF V, KAPLAN G: Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA (1993) 90:5974–5978.
   PubMed Web of Science ®Google Scholar
• NEUBERT R, HELGE H, NEUBERT D: Thalidomide and the Immune system. Down-regulation of the CD26 recep-tor, probably involved in the binding of HIV compo-nents to T-cells in primates. Life Sci. (1994) 30:407–420.
   Google Scholar
• MACKIEWICZ CE, BLACKBOURN DJ, LEVY JA: CD8. T-cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA (1995) 92:2308–2312.
   Google Scholar
• HUMBERT M, DEVERGNE O, CERRINA J, RAIN B, SIMON-NEAU G, DARTEVELLE P, DLTROUX P, GALANAUD P, EMILIE D: Activation of macrophages and cytotoxic cells during cytomegalovirus pneumonia complicating lung transplantations. Am. Rev. Respir. Dis. (1992) 145:1178–1184.
   PubMed Web of Science ®Google Scholar
• HUMBERT M, DELA I IRE RM, FATTAL S, RAIN B, CERRINAJ, DARTEVEI IF P, SIMONNEAU G, DUROUX P, GALANAUD P, EMILIE D: In situ production of interleukin-6 within human lung allografts displaying rejection or cy-tomegalovirus pneumonia. Transplantation ( 1993) 56:623–627.
   PubMed Web of Science ®Google Scholar
• EMILIE D, GALANAUD P: Les cytokines. Viral. (1995)7:14–20.
   Google Scholar
• MURRAY ILW, SQUIRES KE, GASSYUK-BOTEV E: Inter-len:kin-2 treatment, interferon-y induction, and AIDS monocyte activation. Am.'. Med. (1992) 93:234.
   PubMed Web of Science ®Google Scholar
• SQUIRES KE, BROWN ST, ARMSTRONG D, MURPHY WE, MURRAY HW: Interferon-y treatment for Mycobac-terium avium intracellulare complex bacillemia in pa-tients with AIDS. J. Infect. Dis. (1992) 166:686–687.
   PubMed Web of Science ®Google Scholar
• DELEMARRE FGA, STEVENHAGEN A, SNIJDERS F, KREOON FP, VAN EER MY, REISS P, VAN FURTH R: Restoration of the toxoplasmastatic activity of monocytes from AIDS patients during in vivo treatment with interferon-y. J. Infect. Dis. (1993) 168:516–518.
   PubMed Web of Science ®Google Scholar
• ROTH WK, BRANDSTETTER H, STURZ1 M: Cellular andmolecular features of HIV-associated Kaposrs sarcoma. AIDS (1992) 6:895–913.
   PubMed Web of Science ®Google Scholar
• MILES SA, REZAI AR, SALAZAR-GONZALES JS, VAN DERMEYDEN M, STEVENS RH, LOGAN DM, MITSUYASU RT, TAGA T, HIRANO T, KISHIMOTO T, MARTINEZ-MAZA O: AIDS ICaposi sarcoma-derived cells produce and re-spond to iriterleukin-6. Proc. Natl. Acad. Sci. USA (1990) 87:4068–4072.
   PubMed Web of Science ®Google Scholar
• RADKA SF, NAKAMURA S, SAKURADA S, SALAHUDDIN SZ:Correlation of oncostatin M secretion by human retrovirus infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposrs sarcoma. Immunol. (1993) 150:5195–5201.
   Web of Science ®Google Scholar
• ENSOLI B, GENDLEMAN R, MARKHAM P, FIORELLI V, COLOMBINI S, RAFFELD M, CAFARO A, CHANG HK, BRADY JN, GALLO RC: Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposrs sarcoma. Nature (1994) 371:674–680.
   PubMed Web of Science ®Google Scholar
• EMILIE D, TOUITOU R, RAPHAEL M, PEUCHMAUR M, DEVERGNE O, REA D, COUMBARAS J, CREVON MC, EDEL-MAN L, JOAB I, GALANACT) P: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur.J. Immunol. (1992) 22:2937–2942.
   PubMed Web of Science ®Google Scholar
• MASOOD R, ZHANG Y, BOND MW, SCADDEN DT, MOUDGIL T, LAW RE, KAPLAN MII, JUNG B, ESPINA BM, LUNARDI-ESKANDER Y, LEVINE AM, GILL PS: Interleukin-10 is an autocrine growth factor for acquired immu-nodeficiency syndrome-related B-cell lymphoma. Blood (1995) 85:3423–3430.
   PubMed Web of Science ®Google Scholar
• MATSUDA M, SALAZAR F, PETERSSON M, MASUCCI G, HANSSON J, PISA P, ZHANG Q-J, MASUCCI MG, KTESSLING R: Interieultin-10 pretreatment protects target cells from tumor- and alio-specific cytotoxic T-cells and downregulates HLA class I expression. J. Exp. Med. (1994) 180:2371–2376.
   PubMed Web of Science ®Google Scholar
• EMILIE D, COUMBARAS J, RAPHAEL M, DEVERGNE O, DELECLUSE HJ, GISSELBRECHT C, MICHIELS JF, VAN DAMME J, TAGA T, KISHIMOTO T, CREVON MC, GALA- NAUD P: Interleultin-6 production in high grade B-Iym-phomas: correlation with the presence of malignant immunoblasts in acquired inununodeficiency syn-drome and in Human Immunodeficiency Virus-serone-gative patient& Blood (1992) 80:493–504.
   Google Scholar
• EMILIE D, WIJDENES J, GISSELBRECHT C, JARROUSSE B, BILLAUD E, BLAY JY, GABARRE J, GAILLARD JP, BROCHIER J, RAPHAEL M, BOUE F, GALANAUD P: Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lym-phoma: effect on lymphoma growth and on B clinical symptoms. Blood (1994) 84:2472–2479.
   PubMed Web of Science ®Google Scholar
• BECK JT, HSU SM, WIJDENES J, BATAILLE R, KLEIN B, VESOLE D, HAYDEN K, JAGANATH S, BARLOGIE B: Alle-viation of systemic manifestations of Castleman's dis-ease by monoclonal anti-interleukin-6 antibody. New Engl. J. Med. (19940 330:602–605.
   Google Scholar
• MACALLAN DC, NOBLE C, BALDWIN C, JEBB SA, PRENTICE AM, COWARD WA, SAWYER MB, MCMANUS TJ, GRIFFIN GE: Energy expenditure and wasting in human immu-nodeficiency virus infection. New Engl. J. Med. (1995) 333:83–88.
   PubMed Web of Science ®Google Scholar
• GRUNFELD C: What causes wasting in AIDS? New Engl.J.Med. (1995) 333:123–124.
   Google Scholar
• POLI G, KINTER AL, FAUCI AS: Interleultin 1 inducesexpression of the human hrunurtodeficiency virus alone and in synergy with irkterleukin 6 in chronically Infected Ul cells: inhibition of inductive effects by the interleukin 1 receptor antagonist Proc. Natl. Acad. Sci. (1994) 91:108–112.
   PubMed Web of Science ®Google Scholar
• TORNATORE C, NATH A, AMEMIYA K, MAJOR EO: Persist-ent HIV infection in human fetal g,lial cells reactivated by T-cell factor(s) or by the cytoldnes TNFa and IL-13. J. Virol. (1991) 65:6094–6100.
   PubMed Web of Science ®Google Scholar
• MONTANER JL, GORDON S: Th2 downregulation of macrophage HIV-1 replication. Science (1995) 267:538–539.
   PubMed Web of Science ®Google Scholar
• POLI G, BRESSLER P, KINTER A, DUH E, TIMMER WC, RABSON A, JUSTEMENT JS, STANLEY S, FAUCI AS: Inter-leukin-6 induces human imnumodeficiency virus ex-pression in infected monocystic cells alone and in synergy with tumor necrosis factor a by transcriptional and post-transcriptional mechanisms. J. Exp. Med. (1990) 172:151–158.
   PubMed Web of Science ®Google Scholar
• SAVILLE MW, TAGA K, FOLI A, BRODER S, TOSATO G,YARCHOAN R: Interleukin-10 suppresses human immu-nodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood (1994) 83:3591–3599.
   PubMed Web of Science ®Google Scholar
• KOOTSTRA NA, VAN'T WOUT AB, HUISMAN HG, MIEDEMA F, SCHUITEMAKER H: Interference of inter-leukin-10 with human immunodeficiency virus type 1 replication in primary monocyte derived macro-phages. J. Virol. (1994) 68:6967–6975.
   PubMed Web of Science ®Google Scholar
• MONTANER p, DOYLE AG, COLLIN M, IIERBEIN G, ILLEI P, JAMES W, MINTY A, CAPUT D, FERRARA P, GORDON S: Interieukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J. Exp. Med. (1993) 178:743–747.
   PubMed Web of Science ®Google Scholar
• WEISSMAND, POLI G, FAUCI AS: Interleultin-10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin-6 induction of virus. AIDS Res. Hum. Retroviruses (1994) 10:1199–1206.
   PubMed Web of Science ®Google Scholar
• MONTANER LJ, DOYLE AG, COLLIN M, HERBEIN G, ILLEI P, JAMES W, MINTY A, CAPUT D, FERRARA P, GORDON 5: Interleukin-13 inhibits human inununodeficiency vi-rus type 1 production in primary blood-derived human macrophages in vitro. J. Exp. Med. (1993) 178:743–747.
   PubMed Web of Science ®Google Scholar
• ISRAEL N, HAZAN U, ALCAMI J, MUNIER A, ARENZANA-SEISDEDOS F, BACHELERIE F, ISRAEL A, VIRELIZIER JL: Tumor necrosis factor stimulates transcription of In human T-lymphocytes, independently and synergis-tically with mitogens. J. Immunol. (1989) 143:3956–3960.
   PubMed Web of Science ®Google Scholar
• DUD EJ, MAURY WJ, FOLKS TM, FAUCI AS RABSON AB: Tumor necrosis factor a activates human immunodefi-ciency virus type 1 through induction of nuclear factor binding to the NF-k13 sites in the long terminal repeat Proc. Natl. Acad. Sci. USA (1989) 86:5974–5978.
   PubMed Web of Science ®Google Scholar
• FOLKS TM, CLOUSE KA, JUSTEMENT J, RABSON A, DUB E, 10EHRL JH, FAUCI AS: Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell done. Proc. Natl. Acad. Sci. USA (1989) 86:2365–2368.
   PubMed Web of Science ®Google Scholar
• MATSUYAMA T, HAMAMOTO Y, SOMA GI, MIZUNO D, YAMAMOTO N, KOBAYASHI B: Cytocidal effect of tumor necrosis factor on cells chronically infected with hu-man immunodeficiency virus (mV): enhancement of HIV replication. J. Virol. (1989) 63:2504–2509.
   PubMed Web of Science ®Google Scholar
• MELLORS JW, GRIFFITH BP, ORITZ MA, LANDRY ML, RYAN JL: Tumor necrosis factor-a /cathectin enhances hu-man immunodeficiency virus type 1 replication in primary macrophages. I Infect. Dis. (1991) 163:78–82.
   PubMed Web of Science ®Google Scholar
• WELLS DE, CHALIERJEE 5, MULLIGAN MJ, COMPANS RW. Inhibition of human immunodeficiency virus type I Induced cell fusion by recombinant human interferons. J. Virol. (1991) 65:6325–6330.
   Google Scholar
• CHASE MJ, KLEBANOFF SJ: Viriddal effect of stimulated human mononuclear phagocytes on human immu-nodeficiency virus type 1. Proc. Natl. Acad. Sci. USA (1992) 89:5582–5585.
   PubMed Web of Science ®Google Scholar
• EMILIE D, MAILLOT MC, NICHOLAS JF, FIOR R, GALANAUD P: Antagonistic effect of interferon-y on tat-induced transactivation of HIV long terminal repeat. J. Biol. Chem. (1992) 267:20565–20570.
   PubMed Web of Science ®Google Scholar
• WELLS DE, CHATIERJEE S, MULLIGAN MJ, COMPANS RW Virol. (1991) 65:6325–6330.
   Google Scholar
• HAMMER SM, GILLIS JM, GROOPMAN JE, ROSE RM: in vitro modification of human immunodeficiency virus infeo tion by granulocyte-macrophage colony stimulating factor and y interferon. Proc. Natl. Acad. Sci. USA (1986) 83:8734–8738.
   PubMed Web of Science ®Google Scholar
• KORNBLUFH RS, OH PS, MUNIS JR, CLEVELAND PH, RICH-MAN DD: Interferon and bacterial lipopolysaccharide protect macrophages from productive infection by hu-, man immunodeficiency virus in vitro. J. Exp. Med. (1989' 169:1137–1151.
   Google Scholar
• HARTSHORN KL, NEUMEYER D, VOGT MW, SCHOOLE1RT, HIRSCH MS: Activity of interferons alpha, beta alto gamma against human immunodeficiency virus repli-cation in vitro. AIDS Res, Hum. Retroviruses (1987) 3:125–133.
   PubMed Web of Science ®Google Scholar
• WONG GHW, KROWICA JF, STITES DP, GEODDEL DV: Itvitro anti-human immunodeficiency virus activities otumor necrosis factor-a and interferon-7. J. Immunol. (1988) 140:120–124.
   PubMed Web of Science ®Google Scholar
• NAKASHIMA H, YOSHIDA T, HARADA S, YAMAMOTO N:Recombinant human interferon gamma suppresses HTLV-III replication in vitro. Intl Cancer (1986) 38:433–436.
   PubMed Web of Science ®Google Scholar
• COCCLA EM, KREUST B, HOVANESSIAN AG: Specific inhi-bition of viral protein synthesis in HIV-infected cells in response to interferon treatment. (1994) 269:23087–23094.
   Google Scholar
• TISSOT C, MECHTI N: Molecular cloning of a new inter-feron-induced factor that represses human im.munode-ficiency virus type-1 long terminal repeat expression. J. Biol. Chem. (1995) 270:14891–14898.
   Google Scholar
• BISWAS P, POLI G, KINTER AL, JUSTEMENT JS, STANLEY SK, MAURY WJ, BRESSLER P, ORENSTEIN JM, FAUCI AS: Interferon y induces the expression of human immu-nodeficiency virus in persistently infected promono-cytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate ace-tate-differentiated Ul cells. J. Exp. Med. (1992) 176:739–750.
   PubMed Web of Science ®Google Scholar
• POLI G, ORENSTEIN JM, KINTER A, FOLKS TM, FAUCI AS:Interferon a but not AZT suppresses 111V expression in chronically infected cell lines. Science (1989) 244:575–577.
   PubMed Web of Science ®Google Scholar
• FEFtNIE BF, POLI G, FAUCI AS: Alpha interferon sup-presses virion but not soluble human immunodefi-ciency virus antigen production in chronically infected T-lymphocytic cells. J. Virol. (1991) 65:3968–3971.
   PubMed Web of Science ®Google Scholar
• HANSEN BD, NARA PL, MAHESHWARI RK, SIDHU GS, BERNBAUM JG, HOEKZEMA D, MELTZER MS, GENDELMAN HE: Loss of infectivity by progeny virus from alpha Interferon treated human immunodeficiency virus type 1 infected T-cells is associated with defective assembly of envelope gpl 20.]. Viivl. (1992) 66:7543–7548.
   PubMed Web of Science ®Google Scholar
• BACA-REGEN L, HEINZINGER N, STEVENSON M, GENDEL-MAN HE: Alpha interferon induced antiretroviral activi-ties: restriction of viral nucleic acid synthesis and progeny virion production in human immunodefi-ciency virus type 1 infected monocytes. J. Virol. (1994) 68:7559–7565.
   PubMed Web of Science ®Google Scholar
• KOYANAGI Y, O'BRIEN WA, ZHAO JQ, GOLDE DW, GAS-SON JC, CHEN ISY: Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science (1988) 241: 1673-1677.
   Google Scholar
• PERNO CF, COONEY DA, GAO WY, HAO Z, JOHNS DG, FOLI A, HARTMAN, NR, CARLIO R, BRODER S, YARCHOAN R: Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages. Blood (1992) 80:995–1003.
   PubMed Web of Science ®Google Scholar
• FOLKS TM, JUSTEMENT J, KINTER A, DINARELLO CA, FAUCY AS: Cytokine induced expression of UP/-i in a chronically infected promonocyte cell line. Science (1987) 238:800–802.
   PubMed Web of Science ®Google Scholar
• PERNO CF, YARCHOAN R, COONEY DA, HARTMAN NR, WEBB DA, HAO Z, MITSUYA H, JOHNS DG, BRODER S: Replication of human inununodeficiency virus in monocytes. J. Exp. Med. (1989) 169:933–951.
   PubMed Web of Science ®Google Scholar
• PETERSON PK, GEKKER G, CHAO CC, SCHUT R, MOLITOR TW, BALFOUR HT': Cocaine potentiates HIV-1 replication In human peripheral blood mononuclear cell co-cul-tures. J. Immunol. (1991) 146:81–84.
   PubMed Web of Science ®Google Scholar
• LAZDINS JK, KLIMKAIT T, WOODS-COOK K, WALKER M, ALTER' E, COX D, CERLETH N, SHIPMAN R, BILBE G, MCMASTER G: In vitro effect of transforming growth factor-13 on progression of WV-1 infection in primary mononuclear phagocytes. J. Immunol. (1991) 147:1201–1208.
   PubMed Web of Science ®Google Scholar
• POLI G, KINTER AL, JUSTEMENT JS, BRESSLER P, KEHRL JH, FAUCI AS: Transforming growth factor p suppresses human immunodeficiency virus expression and repli-cation in infected cells of the monocyte/macrophage lineage. J. Exp. Med. (1991) 173:589–597.
   PubMed Web of Science ®Google Scholar